Built to make
a different future.

Lee founded Chemify in 2022. He holds the Regius Chair of Chemistry at the University of Glasgow, where his research group developed the foundations of Chemputation. He earned his doctorate at York and is a Fellow of the Royal Society of Chemistry.

Martin brings more than 30 years of financial leadership across start-ups, growing businesses and multinational organisations. An economics graduate and Fellow of the Institute of Chartered Accountants, he leads Chemify’s finance function.

Neil’s career spans operations and supply-chain leadership. Before Chemify, he held senior roles at Virgin Media O2, Amazon and Tesco, including EU Director of Operations at Amazon and Managing Director at Tesco.

Knut builds platforms connecting machine learning, robotics and software. His previous roles include CTO at GuardKnox, CTO Automotive at DXC Technology, engineering leadership at Virgin Hyperloop and IBM Distinguished Engineer. He holds a computer science doctorate from Imperial College.

Swati develops partnerships around chemistry design and synthesis. She brings more than 15 years of experience, including leadership roles at Syngene and Abzena, to Chemify’s business development.

David co-founded Abcam and founded telecoms consultancy Analysys. He chairs Focal Point Positioning and the Cambridge Science Centre, and helped establish Cambridge Angels, Cambridge Network and Cambridge Wireless. His experience connects entrepreneurship, investment and technology.

Steve is a Partner at Triatomic Capital and previously a Partner at Deerfield Management. He has spent more than three decades founding, managing and investing in healthcare technology businesses, and serves as Vice Chairman of Mount Sinai Health System.

Ansu is a physician-scientist, biotechnology founder and Venture Partner at Wing Capital. He is an Associate Professor of Pathology and Immunology at Stanford University, combining academic research with experience building and investing in biotechnology companies.

Jonathan is a Principal at Insight Partners. Previously at McKinsey, he advised healthcare and private-equity clients on growth, acquisitions and turnarounds. He also worked on technology-led innovation at Amadeus and holds master’s degrees in management and international management.

Jason is a co-founder and General Partner at BlueYard Capital. His earlier career includes a General Partner role at Earlybird Venture Capital and executive leadership at Wind River Systems, bringing experience in technology investment and operating businesses.

Rima has built commercial organisations across networking, AI and quantum computing. She was Chief Revenue Officer at IonQ from 2022 to 2025, following enterprise-sales leadership at NVIDIA and engineering and sales leadership at Cisco.

Sandy’s biotechnology leadership includes President, COO and CFO at Resilience, CFO and CBO at Sarepta Therapeutics, and corporate strategy at Celgene. He also serves on the boards of CRISPR Therapeutics and Idorsia Pharmaceuticals.

Torsten is Group President, Enterprise Supply Chain and Chief Supply Chain Officer at 3M. His career includes senior operations and supply-chain positions at SpaceX, Amazon and Henkel, bringing experience in building and scaling physical infrastructure.

Tim is a pharmaceutical executive and former Chief Medical Officer at Eli Lilly. His experience spans clinical development, medical affairs, regulation and drug safety, including bringing therapies in women’s health, endocrinology and neuroscience through approval and launch.

Kim is SVP and Global Head of Artificial Intelligence and Machine Learning at GSK. He previously led AI at Genentech and was Chief Data Scientist at Lumiata. His doctorate in computational drug design is from the University of Melbourne.